In less than 90 minutes, a new, less invasive electrical stimulation technique has been found to improve breathing in people with sleep apnea. The technique, which involves percutaneous hypoglossal ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...

As nights get hotter around the globe due to climate change, the prevalence of sleep apnea is expected to increase by as much ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Learn the biological triggers of grinding and find medical treatments to protect your jaw and sleep better tonight.

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to learn more about the disorder and how leaving it undiagnosed could be impacting ...

Over half of newborns with severe spina bifida experience sleep-disordered breathing, an often overlooked early threat to ...